+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024 - Product Image

Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024

  • ID: 4895826
  • Report
  • December 2019
  • Region: Global
  • 131 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • MORE
Global Allogeneic Stem Cells Market: About this market
The allogeneic stem cells market analysis considers sales from regenerative therapy and drug discovery and development applications. Our study also finds the sales of allogeneic stem cells in Asia, Europe, North America, and ROW. In 2019, the regenerative therapy segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as functional restoration of tissues will play a significant role in the regenerative therapy segment to maintain its market position. Also, our global allogeneic stem cells market report looks at factors such as new product approvals, increasing strategic alliances in the field of regenerative medicines, and investments in the field of regenerative medicines. However, stringent regulations, high cost of allogeneic stem cell therapies, and serious complications associated with stem cell therapies may hamper the growth of the allogeneic stem cell industry over the forecast period.

Global Allogeneic Stem Cells Market: Overview

New product approvals
The new product approvals and special drug designations are anticipated to boost the growth of the market. Based on the application, the allogeneic stem cells market has been segmented into regenerative therapy and drug discovery and development. Manufacturers are increasingly emphasizing innovations and improvisation in the development of regenerative therapies. Many of the regenerative therapeutic candidates have obtained approval for clinical trials in the US, Europe, and APAC due to the efficacy of allogeneic stem cell therapeutics. This is encouraging market players to launch new product lines to stimulate the overall product demand for stem or regenerative therapy using allogeneic stem cell therapeutics and provide better options for their customers. Thus, new product approvals will lead to the expansion of the global allogeneic stem cells market at a CAGR of over 12% during the forecast period.

Special drug designations
Research in the field of stem cell focuses mainly on developing new treatments for deadly diseases, which have negligible treatment using traditional treatment options. Thus, therapeutic candidates, which are currently under development, have been awarded special drug designations by regulatory bodies considering their proven efficacy. Many drugs received designations such as the breakthrough drug designation and the orphan drug designation from regulatory bodies such as the US FDA and the EMA. Drug designations enhance the research and enable drugs to reach the market and provides strong incentives, which in turn, encourages vendors to expedite R&D on novel therapies such as allogeneic stem cell therapy. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of a few major players, the global allogeneic stem cells market is highly concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading allogeneic stem cells manufacturers, that include Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.

Also, the allogeneic stem cells market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Regenerative therapy - Market size and forecast 2019-2024
  • Drug discovery and development - Market size and forecast 2019-2024
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Rising awareness of stem cells
  • Increasing R&D activities in stem cell therapy
  • Special drug designations
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Application - Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Regenerative therapy - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Regenerative therapy - Year-over-year growth 2020-2024 (%)
Exhibit 22: Drug discovery and development - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Drug discovery and development - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by application
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: New product approvals
Exhibit 39: Complications associated with stem cell therapies
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Drug designations
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Biosolution Co. Ltd. - Vendor overview
Exhibit 48: Biosolution Co. Ltd. - Business segments
Exhibit 49: Biosolution Co. Ltd. - Key offerings
Exhibit 50: Cynata Therapeutics Ltd. - Vendor overview
Exhibit 51: Cynata Therapeutics Ltd. - Business segments
Exhibit 52: Cynata Therapeutics Ltd. - Organizational developments
Exhibit 53: Cynata Therapeutics Ltd. - Key offerings
Exhibit 54: JCR Pharmaceuticals Co. Ltd. - Vendor overview
Exhibit 55: JCR Pharmaceuticals Co. Ltd. - Business segments
Exhibit 56: JCR Pharmaceuticals Co. Ltd. - Segment focus
Exhibit 57: JCR Pharmaceuticals Co. Ltd. - Key offerings
Exhibit 58: Lineage Cell Therapeutics Inc. - Vendor overview
Exhibit 59: Lineage Cell Therapeutics Inc. - Business segments
Exhibit 60: Lineage Cell Therapeutics Inc. - Geographic focus
Exhibit 61: Lineage Cell Therapeutics Inc. - Key offerings
Exhibit 62: MEDIPOST Co. Ltd. - Vendor overview
Exhibit 63: MEDIPOST Co. Ltd. - Business segments
Exhibit 64: MEDIPOST Co. Ltd. - Organizational developments
Exhibit 65: MEDIPOST Co. Ltd. - Key offerings
Exhibit 66: MiMedx Group Inc. - Vendor overview
Exhibit 67: MiMedx Group Inc. - Business segments
Exhibit 68: MiMedx Group Inc. - Organizational developments
Exhibit 69: MiMedx Group Inc. - Key offerings
Exhibit 70: Osiris Therapeutics Inc. - Vendor overview
Exhibit 71: Osiris Therapeutics Inc. - Business segments
Exhibit 72: Osiris Therapeutics Inc. - Organizational developments
Exhibit 73: Osiris Therapeutics Inc. - Key offerings
Exhibit 74: Stempeutics Research Pvt. Ltd. - Vendor overview
Exhibit 75: Stempeutics Research Pvt. Ltd. - Product segments
Exhibit 76: Stempeutics Research Pvt. Ltd. - Key offerings
Exhibit 77: Takeda Pharmaceutical Co. Ltd. - Vendor overview
Exhibit 78: Takeda Pharmaceutical Co. Ltd. - Business segments
Exhibit 79: Takeda Pharmaceutical Co. Ltd. - Organizational developments
Exhibit 80: Takeda Pharmaceutical Co. Ltd. - Geographic focus
Exhibit 81: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibit 82: Validation techniques employed for market sizing
Exhibit 83: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • MORE
The following companies as the key players in the global allogeneic stem cells market: Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the special drug designations.”

According to the report, one of the major drivers for this market is the new product approvals.

Further, the report states that one of the major factors hindering the growth of this market is the stringent regulations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll